A Hallmark Clinical Study of Cord Blood Therapy in Adults with Ischemic Stroke
The therapeutic application of human umbilical cord blood cells has been an area of great interest for at least the last 25 years. Currently, cord blood cells are approved for reconstitution of the bone marrow following myeloablation in both young and old patients with myeloid malignancies and other...
Main Authors: | Paul R. Sanberg, Jared Ehrhart |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/0963689719854354 |
Similar Items
-
Cord Blood Cell Therapy for Ischemic Stroke
by: Vendrame, Martina
Published: (2004) -
Biodistribution of Infused Human Umbilical Cord Blood Cells in Alzheimer's Disease-Like Murine Model
by: Jared Ehrhart Ph.D., et al.
Published: (2016-01-01) -
Timing of Cord Blood Treatment after Experimental Stroke Determines Therapeutic Efficacy
by: Jennifer D. Newcomb, et al.
Published: (2006-03-01) -
Plasma Derived from Human Umbilical Cord Blood Modulates Mitogen-Induced Proliferation of Mononuclear Cells Isolated from the Peripheral Blood of ALS Patients
by: David J. Eve, et al.
Published: (2016-05-01) -
Amelioration of Ischemic Brain Injury in Rats with Human Umbilical Cord Blood Stem Cells: Mechanisms of Action
by: Laura L. Hocum Stone, et al.
Published: (2016-08-01)